Compensation for Synvisc-One Knee Injection Victims

Did you or a loved one receive a Synvisc-One Knee Injection Recently? Did you know 18,000 of these syringes may be contaminated?

The manufacturer of the Synvisc-One knee injection has initiated an recall of their product hyaluronic acid gel injection for treating arthritis in knees. A batch that contained 18,000 syringes of Synvisc-One tested positive for microbial contamination and has been linked to increased health risks and hospitalization. If you or a loved one was injected with one of these contaminated needles, you may be eligible for compensation.

Synvisc-One, which was approved by the FDA in 2009, generated nearly $410 million in sales last year. The injectable gel is intended to provide relief for patients with osteoarthritis.

Complications Associated with Contaminated Synvisc-One Knee Injections

Use of the recalled Synvisc-One injections poses a serious health risk. Patients suffering following use of contaminated Synvisc-One syringes have experienced horrible complications.

  • Knee pain
  • Swelling
  • Trouble walking
  • Heat or redness
  • Fluid build-up in or around knee

Hyaluronic Acid Injection Information

"because of increased risks for serious adverse events and local adverse events, the administration of these preparations should be discouraged."

Hyaluronic acid is a lubricating fluid that is naturally found in the knee, but degenerates over time in people with osteoarthritis. The effect of the injection used in viscosupplementation is to stimulate cells in the knee to increase production of hyaluronic acid.

In a meta-analysis of 177 reports that included data on more than 12,000 patients with osteoarthritis in the knee, researchers at the Institute of Social and Preventive Medicine at the University of Bern in Switzerland¬†concluded that the treatment “has minimal benefits and potential for harm.”

They write that “because of increased risks for serious adverse events and local adverse events, the administration of these preparations should be discouraged.”

See also:

Stryker Triathlon with ShapeMatch Custom Fit Technology

Depuy Synthes Attune Knee Replacement

Rate This Service

4.5/5 - (128 votes)

Did you or a loved one suffer complications after receiving a Synvisc-One Knee Injection?

Find out if you may qualify for compensation.

Find Out More
Copyright © 2016-2017 Consumer Safety Watch. All Rights Reserved. Privacy / Terms / Disclaimer

Consumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.

Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.